IsoRay Inc (ISR):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:IsoRay Inc (ISR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5332
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IsoRay Inc (IsoRay), formerly Century Park Pictures Corporation, is a medical technology company which develops, manufactures and markets isotope-based personalized brachytherapy products and devices for the treatment of cancer and other malignant tumors. The company produced Cesium-131, a radioactive isotope used in brachytherapy for the treatment of prostate, brain, lung, head, neck and gynecological cancers. Brachytherapy involves placing the radiation sources – seeds – very close to the tumor site in order to destroy the cancer cells. Cesium 131 provides a specifically targeted, quick-acting radiation treatment. Its initial application is the treatment of localized prostate cancer. It serves medical centers, hospitals and clinics across the US. IsoRay is headquartered in Richland, Washington, the US.

IsoRay Inc (ISR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IsoRay Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
IsoRay Inc, Medical Devices Deals, 2012 to YTD 2018 9
IsoRay Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
IsoRay Inc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
IsoRay to Raise USD8.3 Million in Private Placement of Shares 11
IsoRay Completes Private Placement Of Shares For US$14.7 Million 13
IsoRay Raises USD3.38 Million Private Placement Of Shares 14
IsoRay Amends Terms Of Public Offering Of Units For US$3.7 Million 15
IsoRay Inc – Key Competitors 16
IsoRay Inc – Key Employees 17
IsoRay Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
May 03, 2018: IsoRay Announces Third Quarter Fiscal 2018 Revenue of $1.57 Million, 23% Third Quarter-Over-Third Quarter Increase 19
Apr 18, 2018: IsoRay Announces Preliminary Third Quarter Fiscal 2018 Financial Results 20
Jan 24, 2018: IsoRay Announces Preliminary Second Quarter F2018 Revenue of $1.54 Million, 50% Year-over-Year Increase 21
Nov 14, 2017: IsoRay Announces First Quarter Fiscal 2018 Financial Results 22
Aug 04, 2017: IsoRay Announces Preliminary Fourth Quarter F2017 Revenue of $1.37 Million, 22% Year-over-Year Increase 23
May 10, 2017: IsoRay Announces Third Quarter Fiscal 2017 Financial Results 24
Feb 08, 2017: IsoRay Announces Second Quarter Fiscal 2017 Financial Results 26
Corporate Communications 28
Jun 19, 2018: IsoRay Announces Entry into Employment Agreement with Lori A. Woods as Interim CEO 28
Jun 05, 2018: IsoRay Announces Senior Management Change 29
Legal and Regulatory 30
Mar 09, 2017: IsoRay Announces Final Court Approval of Class Action Settlement 30
Product News 31
May 01, 2018: Sharpening the focus on focal therapy for prostate cancer treatment 31
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
IsoRay Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IsoRay Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IsoRay Inc, Deals By Therapy Area, 2012 to YTD 2018 8
IsoRay Inc, Medical Devices Deals, 2012 to YTD 2018 9
IsoRay Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
IsoRay to Raise USD8.3 Million in Private Placement of Shares 11
IsoRay Completes Private Placement Of Shares For US$14.7 Million 13
IsoRay Raises USD3.38 Million Private Placement Of Shares 14
IsoRay Amends Terms Of Public Offering Of Units For US$3.7 Million 15
IsoRay Inc, Key Competitors 16
IsoRay Inc, Key Employees 17
IsoRay Inc, Subsidiaries 18

List of Figures
IsoRay Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IsoRay Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IsoRay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
IsoRay Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[IsoRay Inc (ISR):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SynteractHCR Inc-製薬・医療分野:企業M&A・提携分析
    Summary SynteractHCR Inc (SynteractHCR), a subsidiary of Amulet Capital Partners LP is a contract research organization that offers clinical trials support services. The organization provides phase I – IV clinical development services, clinical services, vendor management, study document development …
  • NRG Energy Inc (NRG):企業の財務・戦略的SWOT分析
    NRG Energy Inc (NRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Samsung Electronics Co Ltd (005930)-医療機器分野:企業M&A・提携分析
    Summary Samsung Electronics Co., Ltd. (Samsung) is a manufacturer of consumer electronics, information technology and mobile communications, and device solutions. The company’s product portfolio includes television (TV), washing machine, refrigerator, air conditioner, medical devices, monitor, print …
  • Nestle SA:企業のM&A・事業提携・投資動向
    Nestle SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nestle SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • MakeMyTrip Limited:企業の戦略・SWOT・財務分析
    MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report Summary MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Luzhou Bio-chem Technology Limited:企業の戦略・SWOT・財務分析
    Luzhou Bio-chem Technology Limited - Strategy, SWOT and Corporate Finance Report Summary Luzhou Bio-chem Technology Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Power Grid Corporation of India Limited:企業の戦略・SWOT・財務分析
    Power Grid Corporation of India Limited - Strategy, SWOT and Corporate Finance Report Summary Power Grid Corporation of India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Hudson Global Inc (HSON):企業の財務・戦略的SWOT分析
    Hudson Global Inc (HSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sinopec Shanghai Petrochemical Company Limited:戦略・SWOT・企業財務分析
    Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Biglari Holdings Inc.:企業の戦略・SWOT・財務情報
    Biglari Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Biglari Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Edison International:企業の戦略・SWOT・財務情報
    Edison International - Strategy, SWOT and Corporate Finance Report Summary Edison International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sichuan Chuantou Energy Company Ltd (600674):電力:M&Aディール及び事業提携情報
    Summary Sichuan Chuantou Energy Company Ltd (Sichuan Investment Energy), a subsidiary of Sichuan Investment Group Co Ltd is an investment holding company. The company’s business activities include operation of hydropower stations, thermal power plant and power generation plants. It develops, constru …
  • Alabama Municipal Electric Authority:電力:M&Aディール及び事業提携情報
    Summary Alabama Municipal Electric Authority (AMEA) is a not-for-profit publicly-owned electric utility that generates, procures, and supplies power. The authority generates electricity from sources such as gas and solar. AMEA procures electricity from open market and South Carolina Public Service A …
  • Finnish Funding Agency for Innovation-製薬・医療分野:企業M&A・提携分析
    Summary Finnish Funding Agency for Innovation (Tekes) is a financing organization that offers research and technological development programs. The organization offers financial services for research, development and novelty. It provides finance for research and development of new technologies, busin …
  • ReShape Medical Inc-医療機器分野:企業M&A・提携分析
    Summary ReShape Medical Inc (ReShape Medical) is a medical device company that offers weight loss solutions. The company provides dual intragastric balloon for weight loss. Its product comprises of ReShape Duo, a non surgical dual-intragastric balloon used in the treatment of obese or overweight pat …
  • Construcciones y Auxiliar de Ferrocarriles SA:戦略・SWOT・企業財務分析
    Construcciones y Auxiliar de Ferrocarriles SA - Strategy, SWOT and Corporate Finance Report Summary Construcciones y Auxiliar de Ferrocarriles SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Galp Energia SGPS SA (GALP):電力:M&Aディール及び事業提携情報
    Summary Galp Energia SGPS SA (Galp) is an integrated energy company. It explores for, develops and produces crude oil and natural gas, refines crude oil, and markets refined petroleum products. The company also conducts power generation, produces biodiesel and trades gas. It imports, transports and …
  • Theralase Technologies Inc (TLT):企業の財務・戦略的SWOT分析
    Summary Theralase Technologies Inc (Theralase) is a clinical stage pharmaceutical company which specializes in design, development, and manufacturing of laser based technologies used in wide range of bio-destructive and bio-simulative clinical applications. The company is focused on the development …
  • Noront Resources Ltd:企業のM&A・事業提携・投資動向
    Noront Resources Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Noront Resources Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • BioIQ Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioIQ Inc (BioIQ) is a healthcare technology company that offers health and wellness programs. The company’s dimensions screening platforms comprise lab testing, physician results, at-home testing, and flu vaccinations, among others. It offers axis integration platforms such as Bioiq ecosyst …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆